Development of New Chemical Methods for Waste Management in Future Nuclear Fuel Cycles
Submitting Institution
University of ReadingUnit of Assessment
ChemistrySummary Impact Type
TechnologicalResearch Subject Area(s)
Chemical Sciences: Inorganic Chemistry, Other Chemical Sciences
Engineering: Chemical Engineering
Summary of the impact
The research groups of Professor Laurence Harwood and Dr Michael Hudson
(now retired) at the University of Reading have developed new and highly
selective extractants for spent and reprocessed nuclear fuels. These novel
extractants remove specifically the components in nuclear waste that have
the highest levels of long-term radioactivity. The extracted components
(minor actinides) may subsequently be converted — "transmuted" — into
elements with greatly reduced radioactivity. Storage times for high-level
nuclear waste can thus be reduced by a factor of a thousand, typically
from 300,000 to 300 years. This significant advance in the management of
nuclear waste means that next-generation nuclear power production will be
safer, more economical and more sustainable, as well as increasing the
wider acceptance of nuclear power as a viable alternative to fossil fuels.
The newly-developed extractants are now available commercially through
TechnoComm Ltd.
Underpinning research
Much of the uranium and plutonium in spent nuclear fuel can be recovered
and re-used for power generation. However, 3% of the residual waste from
current nuclear fuel cycles is extremely radiotoxic and must be stored for
some 300,000 years before it can be considered safe. This long-term
radiotoxicity arises from the presence of highly radioactive minor
actinides (americium, curium and neptunium), though these constitute less
than 0.1% of the spent fuel. If these active components can be separated
from the accompanying lanthanides, they can be converted to short-lived or
non-fissile elements by neutron bombardment, a process known as
"transmutation", in the next generation of nuclear reactors ("Generation
IV"). Such reactors are due for deployment between 2020 and 2030 and
represent major advances in sustainability, safety, resilience and
economics. Transmutation of the minor actinides will reduce waste-storage
times a thousand-fold, to only some 300 years. However, separation of the
minor actinides from the accompanying lanthanides is essential for
transmutation to succeed, as the lanthanides preferentially absorb
neutrons in the reactor, so acting as "neutron poisons".
The challenge of separating very similar chemical species in nuclear
waste is made even more difficult by the operating conditions under which
it must be carried out: strong radioactive flux and extreme acidicity. In
2003, it was shown by researchers at the University of Reading, working
with the French Atomic Energy Commission, that bis(triazinyl)-pyridine
ligands (BTPs) can selectively extract minor actinides from lanthanides,
with a selectivity of around 30:1. However, while these BTPs provided good
selectivity under laboratory conditions, they proved unstable under the
conditions experienced during nuclear waste reprocessing.[1]
Building on this discovery, University of Reading researchers then went
on to develop stable extractant molecules that can separate the
minor actinides from the chemically very similar lanthanides in nuclear
waste. Since 2000, Dr M. J. Hudson (Lecturer/Reader 1972-2005), Dr C. E.
Boucher (Ph.D. student, 2000-2003), Dr T. A. Youngs (Ph.D. student,
2000-2004), Dr M. R. St. J. Foreman (PDRA, 2001-2007), Dr F. W. Lewis
(PDRA, 2008-2012) Dr A. W. Smith (PDRA, 2013 — present) and Prof. L. M.
Harwood (Professor of Organic Chemistry, 1995 — present) have carried out
this research.
The research undertaken at the University of Reading has led to the
design and synthesis of a new series of selective extractants. The first
of these, dubbed CyMe4BTP was shown to be stable under typical nuclear
reprocessing conditions (high radioactive flux and acidity) and, moreover,
showed an unexpectedly high minor-actinide selectivity of 5000:1 relative
to lanthanides.[2] Subsequent research by the group led to a
second-generation ligand, CyMe4BTBP, which achieved the desired
minor-actinide separation from actual downstream reprocessing waste [3],
enabling the establishment of Europe's first practical Separation of
Actinides and Extraction (SANEX) process. Finally, a third-generation
ligand, CyMe4BTPhen, has most recently been developed, which is
structurally pre-organised and shows considerably faster rates of
extraction. The new ligand achieves high levels of extraction in only 15
minutes, as opposed to several hours for CyMe4BTBP, whilst maintaining
stability and selectivity.[4]
The work at Reading University has been funded by the European Union
through four programmes (PARTNEW, 2000-2003; EUROPART, 2004-2007; ACSEPT,
2008-2012; and SACCSESS, 2013-2015), with combined budgets of over €22M,
and involving more than 30 research institutes throughout Europe and
leading European nuclear-research centres (Commissariat à l'Énergie
Atomique, Marcoule, France; National Nuclear Laboratory, Sellafield, UK;
Karlsruhe Institute of Technology, Karlsruhe, Germany).
References to the research
Key outputs include one Patent Cooperation Treaty (PCT) application and
five papers published in internationally renowned, peer-reviewed journals.
As further indication of the "quality" of these publications, the number
of times each paper has been cited is given in parentheses (retrieved from
Scifinder on 23/10/13):
[1]. M. J. Hudson et al., "The coordination chemistry of
1,2,4-triazinyl bipyridines with lanthanide(III) elements — implications
for the partitioning of americium(III)", Dalton Trans., 1675
(2003). DOI: 10.1039/b301178j. (Cited 42 times).
[2]. M. J. Hudson et al., "New Bis-triazinyl Pyridines for
Americium(III) Extraction", New J. Chem. 8, 1171 (2006). DOI:
10.1039/B514108G. (Cited 79 times).
[3]. L. M. Harwood et al., "The Separation of Americium(III) from
Europium(III) by Two New 6,6'-Bis(triazinyl)-2,2'-bipyridines in Different
Diluents", Solvent Extr. Ion Exch. 29, 551 (2011).
DOI:10.1080/10496475.2011.556989.
[4]. F. W. Lewis et al., "Highly Efficient Separation of
Actinides from Lanthanides by a Phenanthroline-Derived Bis-Triazine
Ligand", J. Am. Chem. Soc. 133, 6950 (2011). DOI:
10.1021/ja203378m. (Cited 36 times). This paper was accompanied by an
article in Chemistry World News on the Royal Society of Chemistry
website" (www.rsc.org/chemistryworld/News/2011/August/09081101.asp)
[6]. F. W. Lewis et al., "Synthesis and Evaluation of Lipophilic
BTBP Ligands for An/Ln Separations in Nuclear Waste Treatment: Effect of
Alkyl Substitution on Extraction Properties and Implications for Ligand
Design", Eur. J. Org. Chem. 8, 1509 (2012). DOI:
10.1002/ejoc.201101576. (Cited 7 times).
Grants: (i) M. J. Hudson, PARTNEW, European Union, 2000-2003, £216,000.
(ii) M. J. Hudson, EUROPART, European Union, 2004-2006, £214,000. (iii) L.
M. Harwood, ACSEPT, European Union, 2009-2011, £265,000. (iv) L. M.
Harwood, MBase, EPSRC, 2010-2014, £149,000. (v) L. M. Harwood, SACSESS,
European Union, 2013-2015, £149,000.
Details of the impact
The UK government is committed to delivering a mixture of energy sources
that will provide a secure, affordable, low-carbon supply of electricity
in the future. Given finite fossil-fuel resources, the pressing need to
reduce carbon emissions worldwide and the inadequacy of alternative means
of electricity generation, such as wind and wave power, nuclear power
represents a major viable source of electricity. In 2012, nuclear energy
accounted for 19% of electricity supply (Digest of UK Energy Statistics
2013, Department of Energy and Climate Change). Given the UK's target of
reducing emissions of greenhouse gases to 20% of their 1990 levels, by
2050, nuclear energy is expected to become increasingly important. By
2050, up to 49% of the UK's electricity generation could be provided by
nuclear power (House of Lords report on Nuclear Research and Development
Capabilities, 2011).
The UK currently has about 4.7 million cubic metres of nuclear waste, of
which 1000 cubic metres is classified as high-level radioactive waste
(Radioactive Wastes in the UK, 2010 Inventory, Nuclear Decommissioning
Authority). This will grow as the UK invests in new nuclear build. The UK,
along with France, currently reprocesses its spent nuclear fuel to recover
unused uranium and plutonium, which can then be used again as fuel. The
residual waste contains highly radioactive minor actinides (americium,
curium and neptunium) as well as corrosion products and non-radioactive
fission products such as lanthanides. Whilst comprising less than 0.1% of
the mass of the spent fuel, the minor actinides constitute the major
long-term hazard, posing extreme, long-term storage problems. They emit
highly penetrating gamma-radiation and generate large amounts of heat,
requiring deep geological storage for more than 300,000 years. Reducing
this nuclear-waste burden would make nuclear power far more sustainable.
One approach to this is through the development of strategies to separate
(partition) and inactivate (transmute) the highly radioactive minor
actinides.
The group in Reading developed the CyMe4BTP ligand during the PARTNEW
programme (2000 - 2003, budget €2.2M, 10 partners) and this led to the
EUROPART (budget €6M, 26 partners) and ACSEPT programmes (budget €9M, 34
partners). During these programes, further research at Reading led to the
discovery of the CyMe4BTBP and CyMe4BTPhen ligands. Within EUROPART and
ACSEPT, partner organisations including the French Atomic Energy
Commission were involved in assessing the minor-actinide selectivity of
the ligands and in measuring their rates of actinide extraction, stripping
qualities, solvent loading and hydrolytic and radiolytic stability. The
European Commission continues to support this work through the SACSESS
programme (€5.5M, 24 partners).[a] The ligands developed at Reading have
been shown to be highly selective for extraction of the minor actinides
(relative to the lanthanides), and they also exhibit significant stability
under the extremely radioactive and highly acidic reprocessing conditions.
Furthermore — and crucially in terms of impact — the CyMe4BTBP ligand has
been shown by workers at the European Commission's Joint Nuclear Research
Centre in Germany to effectively "clean up" real nuclear reprocessing
waste.[b]
The success of the work to develop selective extractants has impacted on
French nuclear policy, as noted in the "National Plan for Management of
Radioactive Materials and Nuclear Waste 2013-2015" where it is stated (p.
214) in Section 4.2. "Separation of minor actinides":
"Research has led to the development of specific extractants and methods
of separation, successfully tested on the laboratory scale for each
process considered: extraction of Americium (EXAM), extraction of
Americium and Curium (SANEX) and group extraction of all actinides
(GANEX)". "In the period 2013-2015 a full scale experiment should be
pursued, from the extraction of several kg of spent fuel obtained from
actual, current processing operations, right through to the production of
pure pellets of Americium dioxide, AmO2. This experiment will
test, across several nuclear laboratories, the sequence of the various
unit operations (separation, isolation, conversion to oxide, pellet
fabrication), and also various related operations including the management
of effluents and by-products."[c]
For use in an industrial setting, these ligands need to be synthesised on
a tonne scale. The Reading group has developed a scalable synthesis of the
CyMe4-diketone, a key precursor to all of the ligands, demonstrating for
the first time the potential for large-scale industrial production of
these compounds. This led to the filing of a patent [d] and the licensing
of intellectual property in this patent from the University of Reading to
TechnoComm Ltd, a company specialising in technology commercialisation in
the chemical sciences.[e] The CyMe4-BTP, CyMe4BTBP and CyMe4-BTPhen
ligands are now manufactured and sold by TechnoComm Ltd.[f] These ligands
have been purchased for process evaluation by leading national and
international nuclear centres such as the NNL (UK), the European
Commission Joint Research Centre (Germany), and the Idaho and Oak Ridge
National Laboratories (USA), demonstrating that these organisations
recognise the potential of the new compounds for effectively treating
nuclear waste.
Funding to develop a full-scale industrial process for separating minor
actinides from nuclear reprocessing waste awaits EU approval. However, the
demonstration that CyMe4BTBP shows excellent efficiency and selectivity
for the minor actinides on real nuclear reprocessing waste has provided
first proof of concept for industrial scale chemical partitioning of the
minor actinides and demonstrates the potential to revolutionise nuclear
waste management. Not only does it promise to dramatically reduce the
levels of radiotoxicity and waste-heat production, but it also paves the
way to more efficient use of geological nuclear-waste repositories. This
will help to make nuclear power more sustainable, strengthening its role
as a genuine alternative to fossil fuels and helping the UK government to
meet its 2050 greenhouse-gas emission targets. Reading's position within
UK partitioning and transmutation capability has been recognised in a
report by the Select Committee on Science and Technology.[g]
Sources to corroborate the impact
[a]. Chef de Project (SACSESS), Commissariat à l'Énergie Atomique,
Marcoule. (information on budgets and partners involved in the PARTNEW,
EUROPART, ACSEPT and SACSESS consortia). (Contact details provided
separately)
[b]. D. Magnusson et al, "Demonstration of a SANEX process in
centrifugal contactors using the CyMe4-BTBP molecule on a genuine fuel
solution", Solvent Extraction and Ion Exchange, 27, 97, (2009).
DOI:10.1080/07366290802672204.
[c] Translated from "Plan national de gestion des matières et des déchets
radioactifs 2013-2015", Le ministère de l'Ecologie, du Développement
durable et de l'Energie, Paris, 2013.
See: http://www.developpement-durable.gouv.fr/Publication-du-Plan-National-de.html
[d]. L.M. Harwood, M. J. Hudson and F. Lewis, GB 09 22 588.9, 2010;
WO2001/077-81, 2011.
[e]. Contact: CEO of TechnoComm Ltd. (http://www.technocomm.co.uk).
Full details of purchasing establishments and quantities sold are
commercially sensitive.
[f]. Technocomm Ltd http://www.technocomm.co.uk/page15.html
[g]. Oral and written evidence to the Select Committee on Science and
Technology "Inquiry on Nuclear Research and Development Capabilities" 24
May 2011, page 190.
See: http://www.parliament.uk/business/committees/